The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $56.95

Today's change+0.57 +1.01%
Updated August 30 4:00 PM EDT. Delayed by at least 15 minutes.
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $56.95

Today's change+0.57 +1.01%
Updated August 30 4:00 PM EDT. Delayed by at least 15 minutes.

LifePoint Health Inc up (U.S.)$0.57

LifePoint Health Inc closed up Tuesday by (U.S.)$0.57 or 1.01% to (U.S.)$56.95. Over the last five days, shares have gained 1.12%, but sit 3.89% above the 52-week low. Shares have underperformed the S&P 500 by 38.31% during the last year.

Key company metrics

  • Open(U.S.) $56.15
  • Previous close(U.S.) $56.38
  • High(U.S.) $57.09
  • Low(U.S.) $56.15
  • Bid / Ask(U.S.) $56.81 / (U.S.) $56.93
  • YTD % change-22.41%
  • Volume363,680
  • Average volume (10-day)490,049
  • Average volume (1-month)613,577
  • Average volume (3-month)446,398
  • 52-week range(U.S.) $54.82 to (U.S.) $81.20
  • Beta0.82
  • Trailing P/E19.15×
  • P/E 1 year forward16.05×
  • Forward PEG2.33×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.97
Updated August 30 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.48%

Based on its net profit margin of 2.48%, LifePoint Health Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:HealthcareIndustry:Healthcare Facilities

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1,5921,5811,3711,310
Total other revenue--------
Total revenue1,5921,5811,3711,310
Gross profit563553500478
Total cost of revenue1,0291,028871832
Total operating expense1,5621,5441,2881,237
Selling / general / administrative346356286274
Research & development--------
Depreciation / amortization85867270
Interest expense (income), net operating--------
Unusual expense (income)22102
Other operating expenses, total41353031
Operating income30378372
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax30378772
Income after tax20245546
Income tax, total10133126
Net income17225344
Total adjustments to net income--------
Net income before extra. items17225344
Minority interest-3-2-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items17225344
Inc. avail. to common incl. extra. items17225344
Diluted net income17225344
Dilution adjustment--------
Diluted weighted average shares44454646
Diluted EPS excluding extraordinary itemsvalue per share0.380.491.160.94
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.710.501.160.97